Published medical journal Cancer, chemotherapy, and Japanese researchers report Pharmacology testing new drugs, s-1, for possible use against who mesothelioma. Although rare cancer, mesothelioma is not treated, it is estimated that fifteen to twenty thousand deaths annually world.
Mesothelioma due to asbestos, toxic chemicals, which are still used in building and construction. Many countries, including the United States all but stopped using asbestos and enforce strict regulations on the use and removal.
With typical latency period ranging from 20 to 50 years, will continue to be cases of mesothelioma asbestos use height to a standstill for decades. Estimates of "who" incidence of mesothelioma 90-a close year if using asbestos patterns radically unchanged. With no known cure for mesothelioma, and new treatments welcomes mesothelioma victims and their families.
S-1 drug antitomor is used for stomach cancer in Japan and Korea, and China and other Asian countries. Although everything is not available for use in the United States, S-1 recommended for approval to treat stomach cancer in Europe. Developed by pharmaceutical company is known as S-1, Taihu brand name tiisono.
Current consists of mesothelioma treatments of surgery, chemotherapy and radiotherapy and palliative treatments of patients choosing to focus on quality of life rather than cancer treatment directly. Mesothelioma often diagnosed too late in development; life expectancy after diagnosis, ranging from six months to five years. Mesothelioma tumors characterized by irregularly patterned around the lung lining and lining of other abdominal cavities. Mesothelioma who are specifically cancer of the lung lining, while the mesothelioma peritoneal cancer itself affecting other abdominal cavities linings. Although both rare cancers, mesothelioma who are more common than Monday.
S-1 designed to prevent the growth of cancer tumors, as well as other support cancer medicines, 5-Fu. In lab mice study S-1 receive mesothelioma cells in their chest cavities which allowed for the development for some time to test treatments. This wait to simulate late stage patients began to model human mesothelioma treatments. It was reported that the rats responded to S-1, which limit the growth of cancer and survival times for them.
Researchers study concluded that da 1 a good drug promising against who mesothelioma.
This entry was published on Tuesday, 11 January 2011 at 9: 30 am and is filed under General, news, and treatments. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.
No comments:
Post a Comment